{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:11:19Z","timestamp":1791483079952,"version":"4.3.4"},"reference-count":47,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Prescription medicine misuse, especially misuse of opioids has become a major public healthcare issue in many developed countries such as the USA and Australia where this is associated with significant morbidity (Emergency Department visits due to acute toxicity) and mortality. In this review, we looked at the available data obtained from peer\u2010reviewed articles and population surveys to gain an insight into the current situation in the Asia\u2013Pacific region. There is currently limited information available, but data from subpopulation surveys in a number of countries suggests that prescription medicine misuse is likely to be an issue of concern from a public health perspective in the Asia\u2013Pacific region. The available data suggest that misuse prevalence rates and the medicines that are commonly misused are similar to countries such as the USA and UK. Further studies are required to determine the overall prevalence of misuse, the harms associated with this and the sources of drugs being misused so that appropriate interventions can be implemented to tackle issues related to prescription medicine misuse in this region.<\/jats:p>","DOI":"10.1111\/bcp.14638","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T04:58:24Z","timestamp":1604379504000},"page":"1660-1667","source":"Crossref","is-referenced-by-count":19,"title":["Prescription medicine misuse in the Asia\u2013Pacific region: An evolving issue?"],"prefix":"10.1111","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-677X","authenticated-orcid":false,"given":"Wui Ling","family":"Chan","sequence":"first","affiliation":[{"name":"Emergency Department Ng Teng Fong General Hospital  Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7826-7237","authenticated-orcid":false,"given":"David M.","family":"Wood","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK"},{"name":"Reader in Clinical Toxicology King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul I.","family":"Dargan","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' NHS Foundation Trust and King's Health Partners  London UK"},{"name":"Clinical Toxicology St Thomas' Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"National Institute on Drug Abuse. Misuse of prescription drugs. Available athttps:\/\/www.drugabuse.gov\/publications\/misuse-prescription-drugs\/overview. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_3_1","unstructured":"World Health Organization (WHO).Lexicon of Alcohol and Drug Terms Published by the World Health Organization.2006. [accessed 2006]. Available at:http:\/\/www.who.int\/substance_abuse\/terminology\/who_lexicon\/en\/. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_4_1","unstructured":"Statistics in Drug Misuse England.Death related to poisoning by drug abuse.2019. Available athttps:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/statistics-on-drug-misuse\/2019\/part-2-deaths-related-to-poisoning-by-drug-misuse. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_5_1","unstructured":"CDC: Overdose Deaths Involving Opioids Cocaine and Psychostimulants \u2014 United States. 2015\u20132016. Available athttps:\/\/www.cdc.gov\/mmwr\/volumes\/67\/wr\/mm6712a1.htmLast accessed 30 Sept 2020"},{"key":"e_1_2_12_6_1","unstructured":"International Statistics. Available athttps:\/\/www.drugfreeworld.org\/drugfacts\/prescription\/abuse-international-statistics.html. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304265"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"e_1_2_12_9_1","unstructured":"Centres for Disease Control and Prevention: Opioid overdose. Available athttps:\/\/www.cdc.gov\/drugoverdose\/data\/prescribing\/overdose-death-maps.html. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_10_1","unstructured":"Non\u2010medical use of pharmaceuticals. Available athttps:\/\/www.aihw.gov.au\/getmedia\/6767ec5c-f658-40a6-a818-a2dcca434538\/aihw-phe-270-Chapter5-Non-medical.pdf.aspx. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.149252"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12277"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2014.07.009"},{"key":"e_1_2_12_14_1","unstructured":"UNODC: Misuse of prescription drugs: A South Asia perspective. Available athttps:\/\/www.unodc.org\/documents\/southasia\/reports\/Misuse_of_Prescription_Drugs_-_A_South_Asia_Perspective_UNODC_2011.pdf. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_15_1","unstructured":"Drug Abuse: The 20 Countries with the Harshest Drug Laws in the World. Available athttps:\/\/drugabuse.com\/the-20-countries-with-the-harshest-drug-laws-in-the-world\/. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_16_1","unstructured":"American Academy of Family Physicians (AAFP): Pain management and opioid misuse. Available athttps:\/\/www.aafp.org\/patient-care\/public-health\/pain-opioids.html. Last accessed 30 Sept 2020"},{"issue":"2","key":"e_1_2_12_17_1","first-page":"294","article-title":"Problematic use of prescription opioids and medicinal cannabis among patients suffering from chronic pain","volume":"18","author":"Feingold D","year":"2017","journal-title":"Pain Med"},{"issue":"3","key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.47102\/annals-acadmedsg.V42N3p138","article-title":"Pain Association of Singapore Task Force. Evidence\u2010based guidelines on the use of opioids in chronic non\u2010cancer pain\u2010\u2010a consensus statement by the pain Association of Singapore Task Force","volume":"42","author":"Ho KY","year":"2013","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_12_19_1","unstructured":"Addiction in the UK: The Substance Abuse Capital of Europe. Available athttps:\/\/www.addictioncenter.com\/addiction\/addiction-in-the-uk\/. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_20_1","unstructured":"The 10 most commonly abused drugs in the US today. Available athttps:\/\/usaddiction.com\/substances\/10-commonly-abused-drugs-us-today\/. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.016"},{"key":"e_1_2_12_22_1","unstructured":"Worldwide availability of opioids per capita. Available athttps:\/\/www.uwhealth.org\/news\/cleary-opiods\/47671. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.012"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.04.004"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","unstructured":"CDC Morbidity and Mortality Weekly Report (MMWR): Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students \u2014 Youth Risk Behavior Survey United States 2019. Available athttps:\/\/www.cdc.gov\/mmwr\/volumes\/69\/su\/su6901a5.htm. Last assessed 30 Sept 2020","DOI":"10.15585\/mmwr.su6901a5"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2019.08.005"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-009-0499-1"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2009.00092.x"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16br02025"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2014.913633"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826081003692098"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2013.09.013"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15059"},{"issue":"3","key":"e_1_2_12_34_1","first-page":"173","article-title":"Population size estimation of tramadol misusers in urban population in Iran: synthesis of methods and results","volume":"11","author":"Nasiri N","year":"2019","journal-title":"Addict Health"},{"key":"e_1_2_12_35_1","unstructured":"WHO Critical Review Report: Tramadol: Non\u2010medical use abuse and dependence. Available athttps:\/\/www.who.int\/medicines\/access\/controlled-substances\/Tramadol.pdf?ua=1. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2016.1155619"},{"key":"e_1_2_12_37_1","unstructured":"Central Narcotics Bureau. Available athttps:\/\/www.cnb.gov.sg\/about-us#vision. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_38_1","unstructured":"The Straits Times. Students popping 'smart pills' to lift grades. Available athttps:\/\/www.straitstimes.com\/singapore\/education\/students-popping-smart-pills-to-lift-grades. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_39_1","unstructured":"The Straits Times. Students fake ADHD symptoms to get 'brain booster' drug. Available athttps:\/\/www.straitstimes.com\/singapore\/students-fake-adhd-symptoms-to-get-brain-booster-drug. Last accessed 30 Sept 2020"},{"key":"e_1_2_12_40_1","unstructured":"Global Drug Survey. Executive Summary 2019. Available athttps:\/\/www.globaldrugsurvey.com\/wp-content\/themes\/globaldrugsurvey\/results\/GDS2019-Exec-Summary.pdf. Last accessed 30 Sept 2020"},{"issue":"7","key":"e_1_2_12_41_1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.47102\/annals-acadmedsg.V35N7p451","article-title":"Socio\u2010demographic profile and help\u2010seeking behaviour of buprenorphine abusers in Singapore","volume":"35","author":"Winslow M","year":"2006","journal-title":"Annal Acad Med Singapore"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15091978"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.11622\/smedj.2020024"},{"issue":"6","key":"e_1_2_12_44_1","first-page":"453","article-title":"Doctors' awareness and perception of prescription medicine misuse in Singapore. 38th international congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 22\u201325 may 2018, Bucharest, Romania","volume":"56","author":"Chan WL","journal-title":"Clin Toxicol"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30299-8"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13324"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.022"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1635955"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T01:56:09Z","timestamp":1693274169000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,22]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1111\/bcp.14638"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14638","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.159373048.85747007","asserted-by":"object"}]},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,22]]}}}